Assertio Therapeutics, Inc (21) | Business Finance (9)

Browse by Subcategory

Recent Contracts

Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 20, 2020)
Sixth Amendment to Note Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics, Inc., certain subsidiaries of Assertio Therapeutics, Inc. party thereto,... (Filed With SEC on December 12, 2019)
Third Supplemental Indenture, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New York Mellon Trust Company, N.A. as Trustee (Filed With SEC on November 7, 2019)
Form of Exchange Agreement (Filed With SEC on August 9, 2019)
Asset Purchase Agreement, dated February 6, 2020, by and between Assertio Therapeutics Inc. and Collegium Pharmaceutical, Inc (Filed With SEC on February 7, 2020)
Asset Purchase Agreement, dated December 11, 2019, by and among Assertio Therapeutics Inc., Golf Acquiror LLC and, solely for the purposes set forth therein, Celtic Intermediate... (Filed With SEC on December 12, 2019)
Fifth Amendment to Note Purchase Agreement, dated August 9, 2019 (Filed With SEC on August 9, 2019)
Form of Third Supplemental Indenture, expected to be dated on or around August 13, 2019, by and between Assertio Therapeutics, Inc., a Delaware corporation, and the Bank of New... (Filed With SEC on August 9, 2019)
Fourth Amendment to Note Purchase Agreement, dated January 8, 2019 (Filed With SEC on January 9, 2019)